Drug profile · INN
quinapril hydrochloride
QUINAPRIL HYDROCHLORIDE
quinapril hydrochloride (QUINAPRIL HYDROCHLORIDE) is a angiotensin-converting enzyme inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — quinapril hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
quinapril hydrochloride (QUINAPRIL HYDROCHLORIDE) is a angiotensin-converting enzyme inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Angiotensin-converting enzyme inhibitor
Primary target: Angiotensin-converting enzyme
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is quinapril hydrochloride?
quinapril hydrochloride (QUINAPRIL HYDROCHLORIDE) is a angiotensin-converting enzyme inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for quinapril hydrochloride?
QUINAPRIL HYDROCHLORIDE is a marketed brand name for quinapril hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of quinapril hydrochloride?
quinapril hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.